Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 2—February 2009
Dispatch

Vaccine-induced Immunity Circumvented by Typical Mycobacterium tuberculosis Beijing Strains

Kristin KremerComments to Author , Marieke J. van der Werf, Betty K.Y. Au, Dang D. Anh, Kai M. Kam, H. Rogier van Doorn, Martien W. Borgdorff, and Dick van Soolingen
Author affiliations: National Institute for Public Health and the Environment, Bilthoven, the Netherlands (K. Kremer, B.K.Y. Au, D. van Soolingen); KNCV Tuberculosis Foundation, The Hague, the Netherlands (M.J. van der Werf, M.W. Borgdorff); National Institute of Hygiene and Epidemiology, Hanoi, Vietnam (D.D. Anh); Department of Health, Hong Kong Special Administrative Region, People’s Republic of China (K.M. Kam); University of Amsterdam, Amsterdam, the Netherlands (H.R. van Doorn, M.W. Borgdorff)

Main Article

Table 1

Risk factors for atypical Mycobacterium tuberculosis in 678 Beijing strain–infected persons with tuberculosis, Vietnam and the Netherlands

Risk factor Total no. patients infected with Beijing clade No. (%) patients infected with atypical Beijing strain Odds ratio (95% confidence interval)
Crude Adjusted*
Country
Vietnam 268 68 (25.4) 1 1
The Netherlands 410 87 (21.2) 0.79 (0.55–1.14) 0.82 (0.52–1.29)
Sex
M 415 93 (22.4) 1 1
F 219 48 (21.9) 0.97 (0.66–1.44) 1.01 (0.67–1.51)
Unknown 44 14 (31.8) 1.62 (0.82–3.17) 1.92 (0.90–4.11)
Age, y
<25 164 36 (22.0) 1 1
25–34 215 51 (23.7) 1.11 (0.68–1.80) 1.05 (0.64–1.73)
35–44 140 29 (20.7) 0.93 (0.54–1.61) 0.80 (0.45–1.42)
45–54 51 7 (13.7) 0.57 (0.24–1.36) 0.45 (0.18–1.12)
55–64 36 9 (25.0) 1.19 (0.51–2.75) 1.03 (0.44–2.45)
65–74 50 13 (26.0) 1.25 (0.60–2.60) 1.07 (0.50–2.30)
>75 22 10 (45.5) 2.96 (1.18–7.41) 2.96 (1.15–7.67)
BCG† vaccination
No 249 69 (27.7) 1 1
Yes 265 55 (20.8) 0.68 (0.46–1.03) 0.60 (0.38–0.95)
Unknown 164 31 (18.9) 0.61 (0.38–0.98) 0.61 (0.36–1.04)
Total 678 155 (22.8)

*Adjusted for country, sex, age group, and BCG vaccination.
†BCG, Mycobacterium bovis bacillus Calmette-Guérin.

Main Article

Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external